239
Views
4
CrossRef citations to date
0
Altmetric
Original Research Articles

Collagen gel protects L929 cells from TNFα-induced death by activating NF-κB

, , , , , , , & show all
Pages 456-463 | Received 06 May 2016, Accepted 10 Oct 2016, Published online: 28 Nov 2016

References

  • Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009;326:1216–1219.
  • Lovell CR, Smolenski KA, Duance VC, Light ND, Young S, Dyson M. Type I and III collagen content and fibre distribution in normal human skin during ageing. Br J Dermatol 1987;117:419–428.
  • Uchugonova A, Zhao M, Weinigel M, Zhang Y, Bouvet M, Hoffman RM, Konig K. Multiphoton tomography visualizes collagen fibers in the tumor microenvironment that maintain cancer-cell anchorage and shape. J Cell Biochem 2013;114:99–102.
  • Rasmussen CH, Petersen DR, Moeller JB, Hansson M, Dufva M. Collagen Type I Improves the differentiation of human embryonic stem cells towards definitive endoderm. PloS One 2015;10:e0145389.
  • Dangi-Garimella S, Krantz SB, Barron MR, Shields MA, Heiferman MJ, Grippo PJ, Bentrem DJ, Munshi HG. Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer Res 2011;71:1019–1028.
  • Hodkinson PS, Mackinnon AC, Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Int J Radiation Biol 2007;83:733–741.
  • Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 2003;200:516–525.
  • Gajko-Galicka A. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans. Acta Biochim Pol 2002;49:433–441.
  • Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001;107:255–264.
  • Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation Proc Natl Acad Sci USA 2000;97:9052–9057.
  • Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 1999;19:6367–6378.
  • Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008;30:689–700.
  • Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995;376:167–170.
  • Wooten MW. Function for NF-kB in neuronal survival: regulation by atypical protein kinase C. J Neurosci Res 1999;58:607–611.
  • Papademetrio DL, Lompardia SL, Simunovich T, Costantino S, Mihalez CY, Cavaliere V, Alvarez E. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy. Targeted Oncol 2016;11:183–195.
  • Lin TH, Rosales C, Mondal K, Bolen JB, Haskill S, Juliano RL. Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase. J Biol Chem 1995;270:16189–16197.
  • Fan ST, Mackman N, Cui MZ, Edgington TS. Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. J Immunol 1995;154:3266–3274.
  • Nakanishi C, Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005;5:297–309.
  • Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 2004;119:139–173.
  • Ye Y-C, Yu L, Wang H-J, Tashiro S-i, Onodera S, Ikejima T. TNFα-induced necroptosis and autophagy via suppression of the p38–NF-κB survival pathway in L929 cells. J Pharmacol Sci 2011;117:160–169.
  • Wang HJ, He WQ, Chen L, Liu WW, Xu Q, Xia MY, Hayashi T, Fujisaki H, Hattori S, Tashiro S, Onodera S, Ikejima T. Type I collagen gel protects murine fibrosarcoma L929 cells from TNFalpha-induced cell death. Biochem Biophys Res Commun 2015;457:693–699.
  • Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Archiv 2005;446:475–482.
  • Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001;107:241–246.
  • Wang HJ, Li MQ, Liu W, Yao GD, Xia MY, Hayashi T, Fujisaki H, Hattori S, Tashiro SI, Onodera S, Ikejima T. Gelatin promotes murine fibrosarcoma L929 cell detachment and protects the cells from TNFalpha-induced cytotoxicity. Connect Tissue Res 2016;57:262–269.
  • Orlowski RZ, Baldwin Jr AS. NF-κB as a therapeutic target in cancer. Trends Mol Med 2002;8:385–389.
  • Weaver VM, Lelièvre S, Lakins JN, Chrenek MA, Jones JCR, Giancotti F, Werb Z, Bissell MJ. β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002;2:205–216.
  • Huang Y, Lu Y, Zhang L, Yan J, Jiang J, Jiang H. Perineural dexmedetomidine attenuates inflammation in rat sciatic nerve via the NF-kappaB pathway. Int J Mol Sci 2014;15:4049–4059.
  • Yang C, Fu ZX. PEG-liposomal oxaliplatin combined with nuclear factor-kappaB inhibitor (PDTC) induces apoptosis in human colorectal cancer cells. Oncol Rep 2014;32:1617–1621.
  • Nuutinen U, Simelius N, Ropponen A, Eeva J, Matto M, Eray M, Pellinen R, Wahlfors J, Pelkonen J. PDTC enables type I TRAIL signaling in type II follicular lymphoma cells. Leukemia Res 2009;33:829–836.
  • Zhang J, Zhang DL, Jiao XL, Dong Q. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-kappaB-dependent MMP-9 signal. Eur Rev Med Pharmacol Sci 2013;17:2372–2382.
  • Nakamura T, Lipton SA. Emerging role of protein-protein transnitrosylation in cell signaling pathways. Antioxid Redox Signaling 2013;18:239–249.
  • Zent R, Ailenberg M, Downey GP, Silverman M. ROS stimulate reorganization of mesangial cell-collagen gels by tyrosine kinase signaling. Am J Physiol 1999;276:F278–F287.
  • Garnotel R, Rittie L, Poitevin S, Monboisse JC, Nguyen P, Potron G, Maquart FX, Randoux A, Gillery P. Human blood monocytes interact with type I collagen through alpha x beta 2 integrin (CD11c-CD18, gp150–95). J Immunol 2000;164:5928–5934.
  • Hale AN, Ledbetter DJ, Gawriluk TR, Rucker EB. 3rd Autophagy: regulation and role in development. Autophagy 2013;9:951–972.
  • Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 2012;19:87–95.
  • Shen S, Kepp O, Kroemer G. The end of autophagic cell death? Autophagy 2012;8:1–3.
  • Pei F, Wang HS, Chen Z, Zhang L. Autophagy regulates odontoblast differentiation by suppressing NF-kappaB activation in an inflammatory environment. Cell Death Dis 2016;7:e2122.
  • Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 2009;15:682–689.
  • Yu L, Wan F, Dutta S, Welsh S, Liu Z, Freundt E, Baehrecke EH, Lenardo M. Autophagic programmed cell death by selective catalase degradation Proc Natl Acad Sci USA 2006;103:4952–4957.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.